The abstract is read at the publisher; the summary is JClub's.
Protein misfolding diseases are linked to cardiovascular dysfunction, including microvascular injury and thrombosis, driven by proteostasis failure, oligomer toxicity, amyloid deposition, and inflammation.
- Why it matters: Cardiac and vascular involvement is often under-recognized, yet proteotoxic mechanisms can affect cardiovascular tissues and worsen outcomes, creating a need for clearer hallmarks and earlier detection.
- What they did: This Review defines cardiovascular hallmarks across transthyretin amyloidosis and immunoglobulin light chain amyloidosis, and examines neurodegenerative proteinopathies involving amyloid-β and α-synuclein, alongside diagnostic pathways, biomarkers, and therapies.
- The result: It summarizes diagnostic indicators and therapeutic strategies, while highlighting residual cardiovascular risk and proposing a roadmap for systematic screening, harmonized vascular phenotyping, biomarker-anchored trials, and AI/precision medicine integrating genotype and conformational strain patterns.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.